PharmaVentures Ltd today announced that Paul Phull has joined the company as Senior Director.
With more than 24 years of senior level commercial, business/corporate development and general management experience in the pharmaceutical, biotechnology and medical device industries, Paul will be responsible for developing PharmaVentures’ Corporate Advisory business.
Paul joins PharmaVentures from Sinclair Pharma plc, a UK listed specialty pharmaceutical company, where he was responsible for the development of the international business with a marketing partner network spanning over 80 countries. He was also responsible for corporate development and worked on
the acquisition and integration of European sales and marketing companies in France, Spain and Italy into the Sinclair group. Paul has significant deal making and corporate transaction experience with a broad range and size of companies in Europe, USA, Japan, India and Asia in a number of therapeutic areas.
“I am very pleased to welcome Paul to PharmaVentures,” said Dr Fintan Walton, Chief Executive Officer. “His strategic approach and industry experience will significantly enhance corporate advisory services, particularly with respect to our transactions offerings.”